Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $263.92 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $97.96 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $57.65 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $48.93 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $21.77 | 1 | $0 (2023) |
| Boston Scientific Corporation | $19.66 | 1 | $0 (2023) |
| ABBVIE INC. | $17.95 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $134.16 | 7 | Merck Sharp & Dohme LLC ($57.65) |
| 2022 | $129.76 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($97.96) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/22/2023 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/18/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/11/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/06/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: WATCHMAN_IC | ||||||
| 02/23/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/07/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $97.96 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 112 | 188 | $33,572 | $11,578 |
| 2022 | 2 | 51 | 226 | $35,295 | $11,813 |
| 2021 | 2 | 37 | 111 | $18,765 | $6,633 |
| 2020 | 3 | 73 | 108 | $25,846 | $9,630 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 105 | $14,700 | $5,188 | 35.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 42 | $14,910 | $4,756 | 31.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 17 | 17 | $2,210 | $855.37 | 38.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 24 | $1,752 | $778.32 | 44.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 209 | $29,260 | $9,612 | 32.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $6,035 | $2,201 | 36.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 96 | $13,440 | $4,618 | 34.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 15 | $5,325 | $2,016 | 37.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 39 | 41 | $14,555 | $5,382 | 37.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 21 | 54 | $7,560 | $2,626 | 34.7% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 13 | 13 | $3,731 | $1,621 | 43.5% |
About Shiela Mbae
Shiela Mbae is a Family healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2018. The National Provider Identifier (NPI) number assigned to this provider is 1699266452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shiela Mbae has received a total of $263.92 in payments from pharmaceutical and medical device companies, with $134.16 received in 2023. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($263.92).
As a Medicare-enrolled provider, Mbae has provided services to 273 Medicare beneficiaries, totaling 633 services with total Medicare billing of $39,654. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Latrobe, PA
- Active Since 05/28/2018
- Last Updated 10/21/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1699266452
Products in Payments
- DIFICID (Drug) $57.65
- FARXIGA (Drug) $33.03
- ENTRESTO (Drug) $21.77
- WATCHMAN Access System (Device) $19.66
- TEFLARO (Drug) $17.95
- BRILINTA (Drug) $15.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Latrobe
Elizabeth Byers, Crnp, CRNP
Family — Payments: $1,297
Jennifer Stout, Crnp, CRNP
Family — Payments: $1,206
Dawn Pomaibo, Crnp, CRNP
Family — Payments: $760.95
Dawn Repak, Crnp, CRNP
Family — Payments: $746.81
Lydia Manzini, Crnp, CRNP
Family — Payments: $494.59
Megan Komar, Crnp, CRNP
Family — Payments: $432.33